Best TWAS P=2.15e-54 · Best GWAS P=2.56e-59 conditioned to 1
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | NADKD1 | 0.08 | 0.06 | bslmm | 563 | 0.05 | 1.3e-06 | -0.16 | -5.6 | 1.8e-08 | 0.30 | 0.97 | 0.00 | TRUE |
2 | GTEx | Adrenal Gland | LMBRD2 | 0.19 | 0.01 | lasso | 6 | 0.02 | 6.9e-02 | -4.97 | 5.8 | 5.4e-09 | -0.32 | 0.07 | 0.50 | TRUE |
3 | GTEx | Brain Frontal Cortex BA9 | SPEF2 | 0.39 | 0.23 | enet | 27 | 0.22 | 1.8e-06 | -5.75 | -6.8 | 1.2e-11 | 0.49 | 0.81 | 0.02 | FALSE |
4 | GTEx | Brain Nucleus accumbens basal ganglia | SPEF2 | 0.31 | 0.24 | lasso | 6 | 0.19 | 9.2e-06 | -5.77 | -5.7 | 1.2e-08 | 0.40 | 0.40 | 0.17 | FALSE |
5 | GTEx | Cells Transformed fibroblasts | SPEF2 | 0.26 | 0.01 | enet | 56 | 0.04 | 2.6e-04 | -3.06 | -7.6 | 4.0e-14 | 0.34 | 0.13 | 0.68 | FALSE |
6 | GTEx | Lung | LMBRD2 | 0.13 | 0.03 | enet | 27 | 0.06 | 3.1e-05 | -4.41 | 5.9 | 3.8e-09 | -0.39 | 0.78 | 0.12 | TRUE |
7 | GTEx | Testis | IL7R | 0.25 | 0.19 | lasso | 6 | 0.18 | 2.1e-08 | 7.21 | 7.3 | 2.3e-13 | -0.33 | 0.99 | 0.00 | TRUE |
8 | METSIM | Adipose | SPEF2 | 0.06 | 0.01 | blup | 522 | 0.03 | 4.0e-05 | 3.99 | -6.8 | 1.0e-11 | 0.36 | 0.74 | 0.02 | TRUE |
9 | ROSMAP | Brain Pre-frontal Cortex | CAPSL | 0.05 | 0.02 | lasso | 6 | 0.03 | 2.9e-04 | 7.86 | -8.5 | 2.6e-17 | 0.55 | 0.29 | 0.42 | TRUE |
10 | YFS | Blood | IL7R | 0.03 | 0.01 | bslmm | 467 | 0.01 | 8.1e-05 | 3.65 | 6.3 | 3.4e-10 | -0.39 | 0.82 | 0.05 | TRUE |
11 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | UGT3A2 | 0.04 | 0.00 | blup | 52 | 0.01 | 4.9e-02 | -4.97 | 8.1 | 6.1e-16 | -0.35 | 0.02 | 0.23 | TRUE |
12 | The Cancer Genome Atlas | Breast Invasive Carcinoma | UGT3A2 | 0.06 | 0.02 | blup | 52 | 0.05 | 9.7e-10 | 4.04 | 6.4 | 2.0e-10 | -0.30 | 0.97 | 0.02 | FALSE |
13 | The Cancer Genome Atlas | Colon Adenocarcinoma | UGT3A2 | 0.11 | 0.08 | lasso | 5 | 0.04 | 2.9e-03 | -4.97 | 5.4 | 5.3e-08 | -0.31 | 0.33 | 0.27 | FALSE |
14 | The Cancer Genome Atlas | Glioblastoma Multiforme | SPEF2 | 0.16 | 0.00 | blup | 136 | 0.08 | 1.9e-03 | -5.20 | -5.7 | 1.5e-08 | 0.47 | 0.09 | 0.36 | FALSE |
15 | The Cancer Genome Atlas | Brain Lower Grade Glioma | SPEF2 | 0.03 | 0.04 | lasso | 5 | 0.02 | 8.4e-04 | -5.77 | -5.8 | 8.1e-09 | 0.40 | 0.38 | 0.08 | FALSE |
16 | The Cancer Genome Atlas | Lung Adenocarcinoma | UGT3A2 | 0.11 | 0.09 | lasso | 2 | 0.11 | 6.0e-13 | -4.83 | 5.2 | 2.0e-07 | -0.33 | 1.00 | 0.00 | FALSE |
17 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | IL7R | 0.04 | 0.03 | lasso | 3 | 0.02 | 9.8e-04 | -16.24 | -15.5 | 2.1e-54 | 0.96 | 0.00 | 0.99 | TRUE |
18 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | UGT3A2 | 0.05 | 0.03 | blup | 52 | 0.04 | 2.8e-05 | -4.59 | 5.4 | 5.7e-08 | -0.22 | 0.06 | 0.60 | TRUE |
19 | The Cancer Genome Atlas | Rectum Adenocarcinoma | UGT3A2 | 0.29 | 0.26 | lasso | 4 | 0.26 | 1.0e-06 | -4.59 | 5.5 | 4.5e-08 | -0.32 | 0.03 | 0.91 | FALSE |
20 | The Cancer Genome Atlas | Thyroid Carcinoma | UGT3A2 | 0.05 | 0.00 | blup | 52 | 0.02 | 3.4e-03 | 3.91 | 6.5 | 8.0e-11 | -0.34 | 0.02 | 0.13 | TRUE |